Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France.

Chipaux M, Szurhaj W, Vercueil L, Milh M, Villeneuve N, Cances C, Auvin S, Chassagnon S, Napuri S, Allaire C, Derambure P, Marchal C, Caubel I, Ricard-Mousnier B, N'Guyen The Tich S, Pinard JM, Bahi-Buisson N, de Baracé C, Kahane P, Gautier A, Hamelin S, Coste-Zeitoun D, Rosenberg SD, Clerson P, Nabbout R, Kuchenbuch M, Picot MC, Kaminska A; GRENAT Group.

Epilepsia. 2016 May;57(5):757-69. doi: 10.1111/epi.13368. Epub 2016 Apr 1.

2.

Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.

Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, Rodriguez D, Louha M, Caubel I, Kemlin I, Lion-François L, Goizet C, Guillot L, Moutard ML, Epaud R, Héron B, Charles P, Tallot M, Camuzat A, Durr A, Polak M, Devos D, Sanlaville D, Vuillaume I, Billette de Villemeur T, Vidailhet M, Doummar D.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):956-62. doi: 10.1136/jnnp-2012-302505. Epub 2012 Jul 24.

PMID:
22832740
3.

Combination of infantile spasms, non-epileptic seizures and complex movement disorder: a new case of ARX-related epilepsy.

Poirier K, Eisermann M, Caubel I, Kaminska A, Peudonnier S, Boddaert N, Saillour Y, Dulac O, Souville I, Beldjord C, Lascelles K, Plouin P, Chelly J, Bahi-Buisson N.

Epilepsy Res. 2008 Aug;80(2-3):224-8. doi: 10.1016/j.eplepsyres.2008.03.019. Epub 2008 May 12.

PMID:
18468866
4.

Early development of occipital horns in a classical Menkes patient.

Gérard-Blanluet M, Birk-Møller L, Caubel I, Gélot A, Billette de Villemeur T, Horn N.

Am J Med Genet A. 2004 Oct 1;130A(2):211-3. Review. No abstract available. Erratum in: Am J Med Genet A. 2005 Apr 30;134(3):346.

PMID:
15372525
5.

[Gaucher's disease in children: first clinical signs, natural course and benefits of enzyme replacement therapy].

Caubel I, Billette de Villemeur T, Belmatoug N; Comité d'étude du traitement de la maladie de Gaucher.

Arch Pediatr. 2003 Aug;10(8):681-8. French.

PMID:
12921999
6.

[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease].

Stirnemann J, Caubel I, Kettaneh A, Fain O, Belmatoug N.

Presse Med. 2003 Mar 22;32(11):503-11. Review. French.

PMID:
12733391
7.

[French results of enzyme replacement therapy in Gaucher's disease].

Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.

Bull Acad Natl Med. 2002;186(5):851-61; discussion 861-3. French.

PMID:
12412377
8.

[Gaucher's disease ].

Belmatoug N, Caubel I, Stirnemann J, Billette de Villemeur T.

J Soc Biol. 2002;196(2):141-9. Review. French.

PMID:
12360743
9.

[Neurotoxicity of cytostatic treatments in pediatrics].

Caubel I, Landman-Parker J, Pellegrino B, de Villemeur TB.

Arch Pediatr. 2001 May;8 Suppl 2:322s-324s. French. No abstract available.

PMID:
11394102

Supplemental Content

Loading ...
Support Center